Sign in Membership
Kelly Ke

Kelly Ke

Dec 04, 2024

NHSA Strengthens Control Over Outpatient Spending

Effectively navigating these regulatory changes will have significant and lasting implications for drug manufacturers, particularly in shaping their pricing strategies, reimbursement models, and distribution channel approaches in China.
Nov 06, 2024

Advances in New Technology Add-On Payments for Innovative Medicine in China’s DRG/DIP Framework

In July, China’s National Healthcare Security Administration introduced the CHS-DRG Grouping Plan (Version 2.0), expanding the number of
Oct 15, 2024

▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

Stay ahead of value-based approval and pricing trends for medical services and discover strategic growth opportunities to support clinical and commercial strategies for innovative medical technologies in China.
Oct 02, 2024

Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers

To take advantage of these opportunities, manufacturers must focus on three key success factors.
Aug 28, 2024

Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China

Understanding and strategically applying these trends is crucial for optimizing pricing strategies and enhancing market adoption of innovative medical technologies in China.
Jul 10, 2024

5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment

In China, large medical equipment is managed through a planned allocation and permit system. Medical institutions must follow specific plans, meet clinical and functional requirements, and have the necessary technical infrastructure and qualified staff.
Jul 03, 2024

NHSA Quietly Releases Implementation Guides for Establishing Medical Service Pricing Items

In China, both public and private not-for-profit hospitals are required to adhere to the Medical Service Pricing Catalogs to provide
Jun 26, 2024

China Aims to Establish a High-Quality All-Inclusive Commercial Health Insurance System in Five Years

City Commercial Health Insurance ("Huiminbao") has been rapidly advancing, focusing on protecting the entire population against major illnesses,
Jun 19, 2024

Shanghai Pilots: Leading Value-Based and Risk-Sharing Reimbursement for Medical Consumables in China

Shanghai utilizes value-based pricing negotiations and performance-linked payments for medical consumable reimbursements, providing insights into the future direction of high-value medical consumable reimbursement under China's basic medical insurance.
Jun 12, 2024

China's Commercial Health Insurance Formulary Development: Current State and Future Directions

The commercial health insurance sector in China presents substantial opportunities for growth, with the development of commercial insurance formularies acting